anti-obesity agents (Abbott)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameanti-obesity agents (Abbott)
Drug Alias Nameleptin enhancers (Abbott/Millennium)anti-obesity agents (Abbott/Millennium)ML-106791A-13XFATP4 +[6] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitorsLeptin modulators
TargetsUpdating
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott LaboratoriesMillennium Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A